Is Dulaglutide legal in India?

CDSCO expert-committee minutes from April 2017 describe dulaglutide as an old drug marketed in India, and Lilly's marketing authorisation carried a post-marketing study condition. In December 2020 the committee recommended approval of a new indication already approved by the US FDA, and in May 2024 it recommended adding treatment of type 2 diabetes in patients aged 10 years and older. In July 2026, reviewing a children's trial of another drug, the committee described dulaglutide as a comparator 'not approved in India' for that paediatric population, so whether the paediatric indication was finally granted is not confirmed.